Ryan Egeland [ADDRESS REDACTED] Re: Separation Agreement and Release Dear Ryan:Cardiovascular Systems Inc • May 5th, 2022 • Surgical & medical instruments & apparatus • Minnesota
As you know, your employment with Cardiovascular Systems, Inc. (“CSI”) will end effective at the close of business on March 3, 2022 (the “Separation Date). The purpose of this Separation Agreement and Release letter (“Agreement”) is to set forth the Salary Continuation Benefits and other benefits CSI will provide to you pursuant to the terms and conditions of CSI’s Executive Officer Severance Plan dated August 22, 2018 (the “Executive Officer Severance Plan”) in exchange for your agreement to the terms and conditions of this Agreement. Capitalized terms used but not otherwise defined in this Agreement will have the meaning set forth in Executive Officer Severance Plan. Please note that while we are giving this Agreement to you now for review, you may not execute this Agreement before your Separation Date.
SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENTLoan and Security Agreement • May 5th, 2022 • Cardiovascular Systems Inc • Surgical & medical instruments & apparatus
This Second Amendment to Loan and Security Agreement (this “Amendment”) is entered into this 29th day of March, 2022, by and between SILICON VALLEY BANK, a California corporation (“Bank”) and CARDIOVASCULAR SYSTEMS, INC., a Delaware corporation (“Borrower”).
